Global Strategy Lab, Dahdaleh Institute for Global Health Research, Faculty of Health and Osgoode Hall Law School, York University, 4700 Keele Street, Dahdaleh Building 2120, Toronto, ON, M3J 1P3, Canada.
Department of Global Health and Population, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.
Health Care Anal. 2023 Mar;31(1):1-8. doi: 10.1007/s10728-019-00388-4.
Antimicrobial resistance is one of the greatest public health crises of our time. The natural biological process that causes microbes to become resistant to antimicrobial drugs presents a complex social challenge requiring more effective and sustainable management of the global antimicrobial commons-the common pool of effective antimicrobials. This special issue of Health Care Analysis explores the potential of two legal approaches-one long-term and one short-term-for managing the antimicrobial commons. The first article explores the lessons for antimicrobial resistance that can be learned from recent climate change agreements, and the second article explores how existing international laws can be adapted to better support global action in the short-term.
抗微生物药物耐药性是我们这个时代最严重的公共卫生危机之一。导致微生物对抗微生物药物产生耐药性的自然生物过程带来了一个复杂的社会挑战,需要更有效地管理全球抗微生物药物共同资源,即有效的抗微生物药物的共同储备。本期《卫生保健分析》探讨了管理抗微生物药物共同资源的两种法律方法的潜力,一种是长期的,另一种是短期的。第一篇文章探讨了可以从最近的气候变化协议中吸取的关于抗微生物药物耐药性的经验教训,第二篇文章探讨了如何调整现有国际法以更好地在短期内支持全球行动。